IGF2BP3 and cancer: The luciferase reporter gene assay indicated significant interaction of miR-181a with two predicted target genes, MYBL1 and IGF2BP3. MYBL1 acting as an oncogene, was associated with tumorigenesis [43], and its expression was elevated in human cancers [44], [45].